Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Trimipramine-D3 maleate Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01002068 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-002-068 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-002-068 Supplier MilliporeSigma Supelco Supplier No. T0711ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

Trimipramine is a tricyclic antidepressant prescribed for treatment of depression, insomnia, and chronic pain or as an adjunctive therapy for alcohol or opioid withdrawal. This internal standard is suitable for quantitation of trimipramine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or isotope dilution methods. Trimipramine is marketed under the trade names Surmontil™, Rhotrimine, and Stangyl.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 1185245-93-5
Linear Formula C20D3H23N2 · C4H4O4
MDL Number MFCD09952294
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol (as free base)
Formula Weight 413.52
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.